Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ENDO OPERATIONS

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 54
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

SIGMAPHARM LABS LLC

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 41
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

GILEAD

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 48
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

WATSON LABS INC

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 43
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

APOTEX

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 48
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 52
  • 0 comments

FDA approve TRANEXAMIC ACID

Comment Full text

PHARMACIA

  • FDA Approval
  • Aug. 19, 2024, 08:49 UTC
  • 49
  • 0 comments

FDA approve SOMATROPIN

Comment Full text

ALEMBIC

  • FDA Approval
  • Aug. 19, 2024, 08:49 UTC
  • 46
  • 0 comments

FDA approve DESVENLAFAXINE SUCCINATE

Comment Full text

HIKMA

  • FDA Approval
  • Aug. 19, 2024, 08:49 UTC
  • 53
  • 0 comments

FDA approve ROPIVACAINE HYDROCHLORIDE

Comment Full text

NEXUS

  • FDA Approval
  • Aug. 16, 2024, 15:46 UTC
  • 56
  • 0 comments

FDA approve EPHEDRINE SULFATE

Comment Full text
  • Previous
  • 373
  • 374
  • 375
  • 376
  • 377
  • Next

Search

News categories

  • Technical Exchange News(14657)
  • Event(6229)
  • SEC News(390671)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(238188)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin